Skip to main content
. 2016 Jul 26;7(33):53471–53501. doi: 10.18632/oncotarget.10840

Figure 3. Phosphorylation profile changes following FK228 treatment of HCT-8 and HCT-116 cells.

Figure 3

SILAC, affinity enrichment, and high-resolution LC-MS/MS analysis was used for quantitative phosphoproteomics analysis of HCT-8 and HCT-116 cells following FK228 treatment. Total and differentially phosphorylated sites and phosphorylated proteins were assessed. (A) Sites exhibiting differential phosphorylation patterns in the two cell lines. (B) Differentially phosphorylated proteins between the two cell lines.